Singapore Institute of Advanced Medicine Holdings Ltd. (9G2) Stock Statistics & Valuation Metrics

Singapore Institute of Advanced Medicine Holdings Ltd. has a market cap or net worth of SGD 36.21M. The enterprise value is SGD 84.18M.

Market Cap

SGD 36.21M

Enterprise Value

SGD 84.18M

Singapore Institute of Advanced Medicine Holdings Ltd. has 1,724,092,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,724,092,500

Owned by Insiders

9.11%

Owned by Institutions

―

Singapore Institute of Advanced Medicine Holdings Ltd.’s return on equity (ROE) is -0.45 and return on invested capital (ROIC) is -16.91%.

Return on Equity (ROE)

-0.45

Return on Assets (ROA)

-0.18

Return on Invested Capital (ROIC)

-16.91%

Return on Capital Employed (ROCE)

-0.21

Revenue Per Employee

151.13K

Profits Per Employee

-229.78K

Employee Count

104

Asset Turnover

0.12

Inventory Turnover

11.19

The current PE Ratio of Singapore Institute of Advanced Medicine Holdings Ltd. is -0.66. Singapore Institute of Advanced Medicine Holdings Ltd.’s PEG ratio is -0.01.

PE Ratio

-0.66

PS Ratio

1.55

PB Ratio

0.50

Price to FCF

-3.76

Price to Operating Cash Flow

-2.96

PEG Ratio

-0.01

In the last 12 months, Singapore Institute of Advanced Medicine Holdings Ltd. had revenue of 15.72M and earned -23.90M in profits. Earnings per share was -0.02.

Revenue

15.72M

Gross Profit

14.50M

Operating Income

-20.20M

Pretax Income

-23.89M

Net Income

-23.90M

EBITDA

-8.97M

Earnings Per Share (EPS)

-0.02

In the last 12 months, operating cash flow was -3.70M and capital expenditures -488,795, giving a free cash flow of -4.19M billion.

Operating Cash Flow

-3.70M

Free Cash Flow

-4.19M

Free Cash Flow per Share

-0.01

Singapore Institute of Advanced Medicine Holdings Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-26.61%

Earnings Yield

-140.34%

Beta

-0.43

52-Week Price Change

-52.27%

50-Day Moving Average

0.03

200-Day Moving Average

0.03

Relative Strength Index (RSI)

1.28

Average Volume (3m)

874.66K

Singapore Institute of Advanced Medicine Holdings Ltd. upcoming earnings date is Feb 12, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 08, 2026

Next Earnings Date

Feb 12, 2027

Ex-Dividend Date

―

Singapore Institute of Advanced Medicine Holdings Ltd. as a current ratio of 0.52, with Debt / Equity ratio of 115.80%

Current Ratio

0.52

Quick Ratio

0.52

Debt to Market Cap

0.80

Net Debt to EBITDA

-5.14

Interest Coverage Ratio

-4.90

In the past 12 months, Singapore Institute of Advanced Medicine Holdings Ltd. has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

Singapore Institute of Advanced Medicine Holdings Ltd. EV to EBITDA ratio is -5.53, with an EV/FCF ratio of -8.54.

EV to Sales

3.52

EV to EBITDA

-5.53

EV to Free Cash Flow

-8.54

EV to Operating Cash Flow

-9.13

Singapore Institute of Advanced Medicine Holdings Ltd. has SGD 15.18M in cash and marketable securities with SGD 61.28M in debt, giving a net cash position of -SGD 46.10M billion.

Cash & Marketable Securities

SGD 15.18M

Total Debt

SGD 61.28M

Net Cash

-SGD 46.10M

Net Cash Per Share

-SGD 0.03

Tangible Book Value Per Share

SGD 0.04

Gross margin is -21.55%, with operating margin of -131.58%, and net profit margin of -159.96%.

Gross Margin

-21.55%

Operating Margin

-131.58%

Pretax Margin

-159.91%

Net Profit Margin

-159.96%

EBITDA Margin

-63.66%

EBIT Margin

-135.38%

The average price target for Singapore Institute of Advanced Medicine Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-1.27%

EPS Growth Forecast

16.67%

Smart Score

―

AI Score

42